842 related articles for article (PubMed ID: 18070166)
41. Wasp venom immunotherapy induces activation and homing of CD4(+)CD25(+) forkhead box protein 3-positive regulatory T cells controlling T(H)1 responses.
Kerstan A; Albert C; Klein D; Bröcker EB; Trautmann A
J Allergy Clin Immunol; 2011 Feb; 127(2):495-501.e1-6. PubMed ID: 21195472
[TBL] [Abstract][Full Text] [Related]
42. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
43. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
44. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
[TBL] [Abstract][Full Text] [Related]
45. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
[TBL] [Abstract][Full Text] [Related]
46. [The basophilic histamine liberation test as a diagnostic method in Hymenoptera venom allergy].
Przybilla B; Ring J; Wielgosch J
Hautarzt; 1988 Oct; 39(10):662-70. PubMed ID: 2466814
[TBL] [Abstract][Full Text] [Related]
47. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
Gawlik R; Glück J; Jawor B; Rogala B
Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
[TBL] [Abstract][Full Text] [Related]
48. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
[TBL] [Abstract][Full Text] [Related]
50. Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients.
Niedoszytko M; Bruinenberg M; de Monchy J; Weersma RK; Wijmenga C; Jassem E; Elberink JN
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):502-10. PubMed ID: 21624750
[TBL] [Abstract][Full Text] [Related]
51. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
52. Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.
Scherer K; Weber JM; Jermann TM; Krautheim A; Tas E; Ueberschlag EV; Cammarata M; Bircher AJ
Int Arch Allergy Immunol; 2008; 146(2):122-32. PubMed ID: 18204278
[TBL] [Abstract][Full Text] [Related]
53. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
54. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
Gentlesk MJ; Halpern GM; Mansmann HC
Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
[TBL] [Abstract][Full Text] [Related]
55. Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.
Brasch J; Maidusch T
Acta Derm Venereol; 2009; 89(5):466-9. PubMed ID: 19734970
[TBL] [Abstract][Full Text] [Related]
56. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT.
Wei W; Liu Y; Wang Y; Zhao Y; He J; Li X; Shen K
Int Arch Allergy Immunol; 2010; 153(1):19-26. PubMed ID: 20357481
[TBL] [Abstract][Full Text] [Related]
57. Hymenoptera venom allergy.
Ebo DG
Verh K Acad Geneeskd Belg; 2007; 69(4):213-30. PubMed ID: 17821959
[TBL] [Abstract][Full Text] [Related]
58. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
Baenkler HW; Meusser-Storm S; Eger G
Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
[TBL] [Abstract][Full Text] [Related]
59. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
[TBL] [Abstract][Full Text] [Related]
60. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
